JPMorgan initiates TRex Bio stock coverage with overweight rating
Covered in this story
What has happened since
- Trex is up 5.5% since this was published, 11 days ago.
- TRex Bio is down 0.4% since this was published, 11 days ago.
Price move measured from the close nearest publication to the latest quote.
Tracked from this story
JPMorgan’s $20 target on $TRXB is on the record and being tracked to Nov 2027 (12-month default), scored on the close that day.
JPMorgan’s track record →Analyst targets on Trex
- Deutsche Bank: at $43.8 · target $57 by Oct 2027 · Buy via Investing.com
“At” is the closing price nearest the day the target was reported, the price we score it from; it is not an earlier target. Published targets verified against independent reporting and tracked to their dates. Not recommendations from Dalsna Finance.
Call it yourself
No member calls on $TREX yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.
Make the first call on Trex →Summary aggregated from Investing.com's public RSS feed. The full reporting belongs to Investing.com — please read it on their site.